Evidence map›Paper›PMID 20595653›Full record

ArticleCirculation research2010

Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion.

Hiromitsu Takagi, Chiao-Po Hsu, Katsuya Kajimoto, Dan Shao, Yanfei Yang, Yasuhiro Maejima, Peiyong Zhai, Ghassan Yehia, Chikaomi Yamada, Daniela Zablocki and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. PKN1 Is a Novel Regulator of Hippocampal GluA1 Levels.Frontiers in synaptic neuroscience · 2021
    Article
  10. Role of DJ-1 in Modulating Glycative Stress in Heart Failure.Journal of the American Heart Association · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. PKC and PKN in heart disease.Journal of molecular and cellular cardiology · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution.

Hiromitsu TakagiCardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, 185 S Orange Avenue, Newark, NJ 07103, USA.
Chiao-Po Hsu
Katsuya Kajimoto
Dan Shao
Yanfei Yang
Yasuhiro Maejima
Peiyong Zhai
Ghassan Yehia
Chikaomi Yamada
Daniela Zablocki
Junichi Sadoshima
Rutgers New Jersey Medical School

Funding

Molecular Mechanisms in Chronically Stunned MyocardiumP01HL069020 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, DOROTHY EILEEN · 2001 to 2014
$21.3M
SARCOMERIC PROTEIN MUTATIONS IN HYPERTROPHY AND HEART FAILUREP01HL059139 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 1997 to 2007
$12.4M
Longevity and Stress ResistanceP01AG027211 · NIA · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI VATNER, STEPHEN F · 2007 to 2013
$10.3M
Cysteine oxidation in the heartR01HL091469 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI Junichi Sadoshima · 2008 to 2026
$9.4M
The Role of Thioredoxin in the Aging HeartR01AG023039 · NIA · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SADOSHIMA, JUNICHI · 2004 to 2018
$5.8M
Regulation of myocardial growth and death by GSK-3R01HL067724 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SADOSHIMA, JUNICHI · 2000 to 2018
$5.1M
Regulation of myocardial growth and death by autophagyR01HL102738 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SADOSHIMA, JUNICHI · 2010 to 2014
$2.5M
Anti-aging and Stress Resistance by Sir2R01AG028787 · NIA · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SADOSHIMA, JUNICHI · 2006 to 2006
$319k
'Death'and 'MAPK'pathways with myocardial ischemiaR01HL067727 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SADOSHIMA, JUNICHI · 2001 to 2001
$236k
NHLBI NIH HHS HL102738NHLBI NIH HHS HL 59139NHLBI NIH HHS HL67724NHLBI NIH HHS HL69020NHLBI NIH HHS HL91469NHLBI NIH HHS P01 HL059139NHLBI NIH HHS P01 HL069020NHLBI NIH HHS R01 HL067724NHLBI NIH HHS R01 HL067727NHLBI NIH HHS R01 HL091469NHLBI NIH HHS R01 HL102738NIA NIH HHS AG27211NIA NIH HHS P01 AG027211NIA NIH HHS R01 AG023039NIA NIH HHS R01 AG028787
6 · The paper itself

Abstract

rationaleThe function of PKN, a stress-activated protein kinase, in the heart is poorly understood.

objectiveWe investigated the functional role of PKN during myocardial ischemia/reperfusion (I/R). METHODS AND

resultsPKN is phosphorylated at Thr774 in hearts subjected to ischemia and reperfusion. Myocardial infarction/area at risk (MI/AAR) produced by 45 minutes of ischemia and 24 hours of reperfusion was significantly smaller in transgenic mice with cardiac-specific overexpression of constitutively active (CA) PKN (Tg-CAPKN) than in nontransgenic (NTg) mice (15+/-5 versus 38+/-5%, P<0.01). The number of TUNEL-positive nuclei was significantly lower in Tg-CAPKN (0.3+/-0.2 versus 1.0+/-0.2%, P<0.05). Both MI/AAR (63+/-9 versus 45+/-8%, P<0.05) and the number of TUNEL-positive cells (7.9+/-1.0 versus 1.3+/-0.9%, P<0.05) were greater in transgenic mice with cardiac-specific overexpression of dominant negative PKN (Tg-DNPKN) than in NTg mice. Thr774 phosphorylation of PKN was also observed in response to H(2)O(2) in cultured cardiac myocytes. Stimulation of PKN prevented, whereas inhibition of PKN aggravated, cell death induced by H(2)O(2), suggesting that the cell-protective effect of PKN is cell-autonomous in cardiac myocytes. PKN induced phosphorylation of alpha B crystallin and increased cardiac proteasome activity. The infarct reducing effect in Tg-CAPKN mice was partially inhibited by epoxomicin, a proteasome inhibitor.

conclusionsPKN is activated by I/R and inhibits apoptosis of cardiac myocytes, thereby protecting the heart from I/R injury. PKN mediates phosphorylation of alpha B crystallin and stimulation of proteasome activity, which, in part, mediates the protective effect of PKN in the heart.

Indexed as

Ischemic Preconditioning, Myocardialalpha-Crystallin B ChainAnimalsAnimals, NewbornApoptosisCells, CulturedCell SurvivalDisease Models, AnimalEnzyme ActivationHydrogen PeroxideMiceMice, TransgenicMyocardial InfarctionMyocardial ReperfusionMyocardial Reperfusion InjuryMyocytes, Cardiacalpha-Crystallin B ChainCryab protein, mouseepoxomicinHydrogen PeroxideOligopeptidesProtease InhibitorsProteasome Endopeptidase ComplexProteasome InhibitorsProtein Kinase Cprotein kinase NThreonine

Identifiers

PMID20595653
PMCPMC3081566
OpenAlexW2136991451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.